T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TERN
1101
DELISTED
Terns Pharmaceuticals
TERN
| $12.3M | ﹤0.01% |
1,475,679
+1,448,996
| +5,430% | +$11.9M |
|
|
SNV
1102
DELISTED
Synovus
SNV
| $12.2M | ﹤0.01% |
273,271
+2,714
| +1% | +$119K |
|
1103
Sana Biotechnology
SANA
$1.1B
| $12M | ﹤0.01% |
2,889,119
-228,877
| -7% | -$1.2M |
|
1104
Intellia Therapeutics
NTLA
$1.66B
| $12M | ﹤0.01% |
582,532
-662,427
| -53% | -$15.3M |
|
1105
Mohawk Industries
MHK
$9.27B
| $12M | ﹤0.01% |
74,501
+282
| +0.4% | +$40.6K |
|
1106
nVent Electric
NVT
$27.5B
| $11.9M | ﹤0.01% |
168,783
+2,958
| +2% | +$204K |
|
1107
BorgWarner
BWA
$14B
| $11.8M | ﹤0.01% |
325,448
-13,267
| -4% | -$437K |
|
|
BBOT
1108
BridgeBio Oncology
BBOT
$755M
| $11.8M | ﹤0.01% |
1,127,598
-3,079
| -0.3% | -$31.8K |
|
1109
SoFi Technologies
SOFI
$23.8B
| $11.6M | ﹤0.01% |
1,476,893
+916,777
| +164% | +$6.66M |
|
1110
Fidelity National Financial
FNF
$12.8B
| $11.6M | ﹤0.01% |
186,887
-7,394
| -4% | -$415K |
|
1111
Nextpower Inc
NXT
$15.7B
| $11.6M | ﹤0.01% |
309,241
+91,804
| +42% | +$3.83M |
|
1112
Toyota
TM
$223B
| $11.6M | ﹤0.01% |
+64,678
| New | +$12.1M |
|
1113
Aecom
ACM
$8.19B
| $11.5M | ﹤0.01% |
111,124
+18,414
| +20% | +$1.73M |
|
1114
Li Auto
LI
$12B
| $11.4M | ﹤0.01% |
+446,000
| New | +$9.06M |
|
1115
Paycom
PAYC
$9.52B
| $11.4M | ﹤0.01% |
68,611
+2,366
| +4% | +$379K |
|
1116
Oric Pharmaceuticals
ORIC
$1.42B
| $11.4M | ﹤0.01% |
1,114,885
-74,342
| -6% | -$735K |
|
1117
Extreme Networks
EXTR
$3.16B
| $11.3M | ﹤0.01% |
750,308
+49,586
| +7% | +$703K |
|
1118
Rapid7
RPD
$929M
| $11.1M | ﹤0.01% |
279,076
-241,363
| -46% | -$9.07M |
|
1119
Amdocs
DOX
$6.08B
| $11M | ﹤0.01% |
126,182
+26,761
| +27% | +$2.25M |
|
|
APLS
1120
DELISTED
Apellis Pharmaceuticals
APLS
| $10.9M | ﹤0.01% |
378,456
-897,970
| -70% | -$33.3M |
|
1121
Enovis
ENOV
$1.42B
| $10.9M | ﹤0.01% |
252,753
-118,395
| -32% | -$5.28M |
|
1122
Jones Lang LaSalle
JLL
$17B
| $10.8M | ﹤0.01% |
39,904
+2,423
| +6% | +$588K |
|
1123
Home BancShares
HOMB
$6.23B
| $10.7M | ﹤0.01% |
394,952
-16,530
| -4% | -$440K |
|
1124
Hyatt Hotels
H
$16.8B
| $10.7M | ﹤0.01% |
70,142
+7,343
| +12% | +$1.08M |
|
1125
SL Green Realty
SLG
$4B
| $10.7M | ﹤0.01% |
153,058
-450,779
| -75% | -$28.9M |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.